PTC Therapeutics(PTCT)
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Emflaza | Deflazacort | 2017-02-09 | ||
| Translarna | Ataluren | 2014-07-31 | ||
| Upstaza | Eladocagene exuparvovec | 2022-07-18 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use